1. Home
  2. ROAD vs GKOS Comparison

ROAD vs GKOS Comparison

Compare ROAD & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$115.30

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$109.49

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
GKOS
Founded
2001
1998
Country
United States
United States
Employees
N/A
995
Industry
Engineering & Construction
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.3B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ROAD
GKOS
Price
$115.30
$109.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$123.50
$127.71
AVG Volume (30 Days)
480.9K
594.8K
Earning Date
02-05-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
1.84
N/A
Revenue
$2,812,356,000.00
$469,820,000.00
Revenue This Year
$25.23
$31.15
Revenue Next Year
$10.22
$24.15
P/E Ratio
$63.64
N/A
Revenue Growth
54.20
30.38
52 Week Low
$64.79
$73.16
52 Week High
$138.90
$163.71

Technical Indicators

Market Signals
Indicator
ROAD
GKOS
Relative Strength Index (RSI) 57.50 48.46
Support Level $106.61 $109.07
Resistance Level $116.21 $115.00
Average True Range (ATR) 4.19 2.70
MACD 0.49 -1.17
Stochastic Oscillator 72.98 12.13

Price Performance

Historical Comparison
ROAD
GKOS

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: